Treatment of cerebellar tremors with carbamazepine: a controlled trial with long-term follow-up.
We studied the effects of carbamazepine (CBZ) (400 and 600 mg per day) in 10 patients with cerebellar tremors in a single-blind manner. All patients improved on a clinical rating scale and by accelerometric recording; there was no improvement with placebo. Our data suggest that CBZ may be a valuable drug in cerebellar tremors.
Sechi
G P
GP
Department of Neurology, University of Sassari, Italy.
Zuddas
M
M
Piredda
M
M
Agnetti
V
V
Sau
G
G
Piras
M L
ML
Tanca
S
S
Rosati
G
G
D000328:Adult; D002220:Carbamazepine / Q000008:administration & dosage / Q000627:therapeutic use*; D002526:Cerebellar Diseases / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D013997:Time Factors; D014202:Tremor / Q000188:drug therapy*
D002220:Carbamazepine